MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Felodipine

Felodipine 2.5mg modified-release tablets

No stability information

Stability notes for Felodipine 2.5mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (6) of Felodipine 2.5mg modified-release tablets
Cardioplen XL 2.5mg tablets (Chiesi Ltd)
Delofine XL 2.5mg tablets (Morningside Healthcare Ltd)
Felodipine 2.5mg modified-release tablets (AAH Hillcross)
Felodipine 2.5mg modified-release tablets (Teva UK Ltd)
Neofel XL 2.5mg tablets (Kent Pharma (UK) Ltd)
Parmid XL 2.5mg tablets (Sandoz Ltd)

Felodipine 5mg modified-release tablets

No stability information

Stability notes for Felodipine 5mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Felodipine 5mg modified-release tablets
Cardioplen XL 5mg tablets (Chiesi Ltd)
Delofine XL 5mg tablets (Morningside Healthcare Ltd)
Felodipine 5mg modified-release tablets (Teva UK Ltd)
Neofel XL 5mg tablets (Kent Pharma (UK) Ltd)
Vascalpha 5mg modified-release tablets (Accord-UK Ltd)

Felodipine 10mg modified-release tablets

No stability information

Stability notes for Felodipine 10mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (6) of Felodipine 10mg modified-release tablets
Cardioplen XL 10mg tablets (Chiesi Ltd)
Delofine XL 10mg tablets (Morningside Healthcare Ltd)
Felodipine 10mg modified-release tablets (Teva UK Ltd)
Neofel XL 10mg tablets (Kent Pharma (UK) Ltd)
Pinefeld XL 10mg tablets (Tillomed Laboratories Ltd)
Vascalpha 10mg modified-release tablets (Accord-UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.